v3.26.1
Net Loss Per Share - Schedule of the Reconciliation of Basic and Diluted Loss Per Share (Details) - USD ($)
$ / shares in Units, shares in Thousands, $ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2026
Mar. 31, 2026
Jun. 30, 2025
Mar. 31, 2025
Jun. 30, 2026
Jun. 30, 2025
Earnings Per Share [Abstract]            
Net Loss $ (114,986) $ (45,650) $ (44,048) $ (26,080) $ (160,636) $ (70,128)
Less: Net loss attributable to noncontrolling interest (1,486)   (1,740)   (3,866) (1,740)
Deemed dividend for Vivasor preferred shares repurchase (1,229)   0   (1,229) 0
Deemed dividend for anti-dilution adjustments to Oramed Penny Warrants upon reverse stock-split 0   (43,753)   0 (43,753)
Net loss for basic loss per share attributable to common stockholders (114,729)   (86,061)   (157,999) (112,141)
Net loss for diluted loss per share attributable to common stockholders $ (114,729)   $ (86,061)   $ (157,999) $ (112,141)
Weighted average number of shares outstanding 6,892   5,095   6,891 5,080
Weighted average common stock warrants exercisable for nominal consideration 0   6,500   6,500
Weighted average number of shares - basic 6,892   11,595   6,891 11,580
Weighted average number of shares, diluted 6,892   11,595   6,891 11,580
Loss per share, Basic $ (16.65)   $ (7.42)   $ (22.93) $ (9.68)
Loss per share, Diluted $ (16.65)   $ (7.42)   $ (22.93) $ (9.68)